- Home
- INZY vs DSM Comparison
INZY vs DSM Comparison
Compare INZY & DSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INZY
- DSM
- Stock Information
- Founded
- INZY 2015
- DSM 1989
- Country
- INZY United States
- DSM United States
- Employees
- INZY N/A
- DSM N/A
- Industry
- INZY Biotechnology: Pharmaceutical Preparations
- DSM Investment Managers
- Sector
- INZY Health Care
- DSM Finance
- Exchange
- INZY Nasdaq
- DSM Nasdaq
- Market Cap
- INZY 256.3M
- DSM 275.8M
- IPO Year
- INZY 2020
- DSM N/A
- Fundamental
- Price
- INZY N/A
- DSM $5.70
- Analyst Decision
- INZY Buy
- DSM
- Analyst Count
- INZY 9
- DSM 0
- Target Price
- INZY $15.22
- DSM N/A
- AVG Volume (30 Days)
- INZY 989.2K
- DSM 161.7K
- Earning Date
- INZY 08-05-2025
- DSM 01-01-0001
- Dividend Yield
- INZY N/A
- DSM 3.97%
- EPS Growth
- INZY N/A
- DSM N/A
- EPS
- INZY N/A
- DSM N/A
- Revenue
- INZY N/A
- DSM N/A
- Revenue This Year
- INZY N/A
- DSM N/A
- Revenue Next Year
- INZY N/A
- DSM N/A
- P/E Ratio
- INZY N/A
- DSM N/A
- Revenue Growth
- INZY N/A
- DSM N/A
- 52 Week Low
- INZY $0.72
- DSM $4.69
- 52 Week High
- INZY $6.24
- DSM $6.05
- Technical
- Relative Strength Index (RSI)
- INZY 82.67
- DSM 62.53
- Support Level
- INZY $3.94
- DSM $5.55
- Resistance Level
- INZY $3.97
- DSM $5.60
- Average True Range (ATR)
- INZY 0.01
- DSM 0.04
- MACD
- INZY -0.08
- DSM 0.02
- Stochastic Oscillator
- INZY 100.00
- DSM 100.00
About INZY Inozyme Pharma Inc.
Inozyme Pharma Inc is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of diseases impacting bone health and blood vessel function. The company is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies. Its product candidate, INZ-701, is a soluble, recombinant, genetically engineered fusion protein that is designed to correct a defect in a pathway involving ENPP1 and ABCC6 deficiencies.
About DSM BNY Mellon Strategic Municipal Bond Fund Inc.
BNY Mellon Strategic Municipal Bond Fund, Inc. is a diversified closed-end management investment company. Its investment objective is to seek to maximize current income exempt from federal income tax to the extent consistent with the preservation of capital.